Stromal cell-derived factor-1 stimulates cell recruitment, vascularization and osteogenic differentiation

Tissue Engineering - Part A

Volumn 20, Issue 3-4, 2014, Pages 466-473

  Eman, Rhandy M ^a   Öner, F Cumhur ^a   Kruyt, Moyo C ^a   Dhert, Wouter J A ^a,b   Alblas, Jacqueline ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIALS; BONE; CYTOLOGY;

ADDITIVE EFFECTS; BENEFICIAL EFFECTS; BONE SUBSTITUTES; GROWTH FACTOR; HYBRID CONSTRUCTS; LOW CONCENTRATIONS; OSTEOGENIC DIFFERENTIATION; VASCULARIZATION;

CELLS;

BIOCERAMICS; BIOMATERIAL; CD31 ANTIGEN; COLLAGEN TYPE 1; OSTEOCALCIN; STROMAL CELL DERIVED FACTOR 1ALPHA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE CELL; BONE REGENERATION; CAPILLARY; CELL COUNT; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; HYBRIDIZATION; HYDROGEL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULARIZATION;

ANIMALS; ANTIGENS, CD31; BLOOD VESSELS; CELL DIFFERENTIATION; CHEMOKINE CXCL12; COLLAGEN TYPE I; FEMALE; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOGENESIS; PROSTHESIS IMPLANTATION; STROMAL CELLS; TISSUE SCAFFOLDS;

EID: 84894218473     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0653     Document Type: Article

References (35)

1. Yuan, H., Fernandes, H., Habibovic, P., de Boer, J., Barradas, A.M., de Ruiter, A., et al. Osteoinductive ceramics as a synthetic alternative to autologous bone grafting. Proc Natl Acad Sci USA 107, 13614, 2010.
2. Bruder, S.P., Kraus, K.H., Goldberg, V.M., and Kadiyala, S. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am 80, 985, 1998.
3. Kempen, D.H., Lu, L., Heijink, A., Hefferan, T.E., Creemers, L.B., Maran, A., et al. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 30, 2816, 2009.
4. Govender, S., Csimma, C., Genant, H.K., Valentin-Opran, A., Amit, Y., Arbel, R., et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84-A, 2123, 2002.
5. Friedlaender, G.E., Perry, C.R., Cole, J.D., Cook, S.D., Cierny, G., Muschler, G.F., et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 83-A Suppl 1, S151, 2001.
6. Carragee, E.J., Hurwitz, E.L., and Weiner, B.K. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J 11, 471, 2011.
7. Seebach, C., Henrich, D., Kahling, C., Wilhelm, K., Tami, A.E., Alini, M., et al. Endothelial progenitor cells and mes-enchymal stem cells seeded onto beta-TCP granules enhance early vascularization and bone healing in a critical-sized bone defect in rats. Tissue Eng Part A 16, 1961, 2010.
8. Arrington, E.D., Smith, W.J., Chambers, H.G., Bucknell, A.L., and Davino, N.A. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res 329, 300, 1996.
9. Banwart, J.C., Asher, M.A., and Hassanein, R.S. Iliac crest bone graft harvest donor site morbidity. A statistical evaluation. Spine (Phila Pa 1976) 20, 1055, 1995.
10. Geuze, R.E., Kruyt, M.C., Verbout, A.J., Alblas, J., and Dhert, W.J. Comparing various off-the-shelf methods for bone tissue engineering in a large-animal ectopic implantation model: bone marrow, allogeneic bone marrow stromal cells, and platelet gel. Tissue Eng Part A 14, 1435, 2008.
11. Otsuru, S., Tamai, K., Yamazaki, T., Yoshikawa, H., and Kaneda, Y. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway. Stem Cells 26, 223, 2008.
12. Higashino, K., Viggeswarapu, M., Bargouti, M., Liu, H., Titus, L., and Boden, S.D. Stromal cell-derived factor-1 potentiates bone morphogenetic protein-2 induced bone formation. Tissue Eng Part A 17, 523, 2011.
13. Granero-Molto, F., Weis, J.A., Miga, M.I., Landis, B., Myers, T.J., O'Rear, L., et al. Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells 27, 1887, 2009.
14. Kitaori, T., Ito, H., Schwarz, E.M., Tsutsumi, R., Yoshitomi, H., Oishi, S., et al. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum 60, 813, 2009.
15. Kucia, M., Reca, R., Miekus, K., Wanzeck, J., Wojakowski, W., Janowska-Wieczorek, A., et al. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 23, 879, 2005.
16. Mirshahi, F., Pourtau, J., Li, H., Muraine, M., Trochon, V., Legrand, E., et al. SDF-1 activity on microvascular endo-thelial cells: consequences on angiogenesis in in vitro and in vivo models. Thromb Res 99, 587, 2000.
17. Chen, T., Bai, H., Shao, Y., Arzigian, M., Janzen, V., Attar, E., et al. Stromal cell-derived factor-1/CXCR4 signaling modifies the capillary-like organization of human embryonic stem cell-derived endothelium in vitro. Stem Cells 25, 392, 2007.
18. Kuraitis, D., Zhang, P., Zhang, Y., Padavan, D.T., McEwan, K., Sofrenovic, T., et al. A stromal cell-derived factor-1 releasing matrix enhances the progenitor cell response and blood vessel growth in ischaemic skeletal muscle. Eur Cell Mater 22, 109, 2011.
19. Kimura, Y., and Tabata, Y. Controlled release of stromal-cell-derived factor-1 from gelatin hydrogels enhances angiogenesis. J Biomater Sci Polym Ed 21, 37, 2010.
20. De Falco, E., Porcelli, D., Torella, A.R., Straino, S., Iachini-noto, M.G., Orlandi, A., et al. SDF-1 involvement in endo-thelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 104, 3472, 2004.
21. Thevenot, P.T., Nair, A.M., Shen, J., Lotfi, P., Ko, C.Y., and Tang, L. The effect of incorporation of SDF-1alpha into PLGA scaffolds on stem cell recruitment and the inflammatory response. Biomaterials 31, 3997, 2010.
22. Fujio, M., Yamamoto, A., Ando, Y., Shohara, R., Kinoshita, K., Kaneko, T., et al. Stromal cell-derived factor-1 enhances distraction osteogenesis-mediated skeletal tissue regeneration through the recruitment of endothelial precursors. Bone 49, 693, 2011.
23. Soleimani, M., and Nadri, S. A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat Protoc 4, 102, 2009.
24. Geuze, R.E., Prins, H.J., Oner, F.C., van der Helm, Y.J., Schuijff, L.S., Martens, A.C., et al. Luciferase labeling for multipotent stromal cell tracking in spinal fusion versus ectopic bone tissue engineering in mice and rats. Tissue Eng Part A 16, 3343, 2010.
25. Kortesidis, A., Zannettino, A., Isenmann, S., Shi, S., Lapidot, T., and Gronthos, S. Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood 105, 3793, 2005.
26. Ratanavaraporn, J., Furuya, H., Kohara, H., and Tabata, Y. Synergistic effects of the dual release of stromal cell-derived factor-1 and bone morphogenetic protein-2 from hydrogels on bone regeneration. Biomaterials 32, 2797, 2011.
27. Petit, I., Jin, D., and Rafii, S. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol 28, 299, 2007.
28. Lin, R.Z., Moreno-Luna, R., Zhou, B., Pu, W.T., and Melero-Martin, J.M. Equal modulation of endothelial cell function by four distinct tissue-specific mesenchymal stem cells. Angiogenesis 15, 443, 2012.
29. Segers, V.F., Revin, V., Wu, W., Qiu, H., Yan, Z., Lee, R.T., et al. Protease-resistant stromal cell-derived factor-1 for the treatment of experimental peripheral artery disease. Circulation 123, 1306, 2011.
30. Wise, J.K., Sumner, D.R., and Virdi, A.S. Modulation of stromal cell-derived factor-1/CXC chemokine receptor 4 axis enhances rhBMP-2-induced ectopic bone formation. Tissue Eng Part A 18, 860, 2012.
31. Fedorovich, N.E., Haverslag, R.T., Dhert, W.J., and Alblas, J. The role of endothelial progenitor cells in prevascularized bone tissue engineering: development of heterogeneous constructs. Tissue Eng Part A 16, 2355, 2010.
32. Zannettino, A.C., Paton, S., Itescu, S., and Gronthos, S. Comparative assessment of the osteoconductive properties of different biomaterials in vivo seeded with human or ovine mesenchymal stem/stromal cells. Tissue Eng Part A 16, 3579, 2010.
33. Juffroy, O., Noel, D., Delanoye, A., Viltart, O., Wolowczuk, I., and Verwaerde, C. Subcutaneous graft of D1 mouse mesenchymal stem cells leads to the formation of a bone-like structure. Differentiation 78, 223, 2009.
34. Janicki, P., Boeuf, S., Steck, E., Egermann, M., Kasten, P., and Richter, W. Prediction of in vivo bone forming potency of bone marrow-derived human mesenchymal stem cells. Eur Cell Mater 21, 488, 2011.
35. Kruyt, M., De Bruijn, J., Rouwkema, J., Van Bliterswijk, C., Oner, C., Verbout, A., et al. Analysis of the dynamics of bone formation, effect of cell seeding density, and potential of allogeneic cells in cell-based bone tissue engineering in goats. Tissue Eng Part A 14, 1081, 2008.